Time-series modeling of epidemics in complex populations: Detecting changes in incidence volatility over time.

Publication date: Jul 11, 2025

Trends in infectious disease incidence provide important information about epidemic dynamics and prospects for control. Higher-frequency variation around incidence trends can shed light on the processes driving epidemics in complex populations, as transmission heterogeneity, shifting landscapes of susceptibility, and fluctuations in reporting can impact the volatility of observed case counts. However, measures of temporal volatility in incidence, and how volatility changes over time, are often overlooked in population-level analyses of incidence data, which typically focus on moving averages. Here we present a statistical framework to quantify temporal changes in incidence dispersion and to detect rapid shifts in the dispersion parameter, which may signal new epidemic phases. We apply the method to COVID-19 incidence data in 144 United States (US) counties from January 1st, 2020 to March 23rd, 2023. Theory predicts that dispersion should be inversely proportional to incidence, however our method reveals pronounced temporal trends in dispersion that are not explained by incidence alone, but which are replicated across counties. In particular, dispersion increased around the major surge in cases in 2022, and highly overdispersed patterns became more frequent later in the time series. These increases potentially indicate transmission heterogeneity, changes in the susceptibility landscape, or that there were changes in reporting. Shifts in dispersion can also indicate shifts in epidemic phase, so our method provides a way for public health officials to anticipate and manage changes in epidemic regime and the drivers of transmission.

Open Access PDF

Concepts Keywords
Counties Complex
Epidemics Dispersion
Epidemiology Epidemic
Proportional Epidemics
Heterogeneity
Incidence
Populations
Series
Shifts
Susceptibility
Temporal
Time
Transmission
Trends
Volatility

Semantics

Type Source Name
disease IDO infectious disease incidence
disease IDO susceptibility
disease MESH COVID-19
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH ARCS
disease IDO contact tracing
disease IDO process
disease MESH measles
pathway KEGG Measles
disease IDO country
disease MESH influenza
disease MESH infections
disease MESH emergency
disease IDO pathogen
disease IDO host
disease MESH secondary infections
disease IDO infection
drug DRUGBANK Aspartame
disease IDO algorithm
disease MESH infectious diseases
disease MESH reinfections
drug DRUGBANK Esomeprazole
disease IDO intervention
drug DRUGBANK Guanosine
disease MESH stuttering
drug DRUGBANK Serine

Original Article

(Visited 2 times, 1 visits today)